BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18639282)

  • 1. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
    Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
    J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.
    Takahiro T; Shinichi K; Toshimitsu S
    Clin Cancer Res; 2003 Jun; 9(6):2204-12. PubMed ID: 12796387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
    Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
    Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients.
    Alo' PL; Visca P; Marci A; Mangoni A; Botti C; Di Tondo U
    Cancer; 1996 Feb; 77(3):474-82. PubMed ID: 8630954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor of poor outcome in nephroblastoma: an interinstitutional study.
    Camassei FD; Jenkner A; Ravà L; Bosman C; Francalanci P; Donfrancesco A; Alò PL; Boldrini R
    Med Pediatr Oncol; 2003 May; 40(5):302-8. PubMed ID: 12652618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma.
    Horiguchi A; Asano T; Asakuma J; Asano T; Sumitomo M; Hayakawa M
    J Urol; 2004 Aug; 172(2):718-22. PubMed ID: 15247769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
    Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H
    Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma.
    Obara W; Konda R; Akasaka S; Nakamura S; Sugawara A; Fujioka T
    J Urol; 2007 Oct; 178(4 Pt 1):1497-503. PubMed ID: 17707062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis.
    Hashimoto T; Kusakabe T; Sugino T; Fukuda T; Watanabe K; Sato Y; Nashimoto A; Honma K; Kimura H; Fujii H; Suzuki T
    Pathobiology; 2004; 71(5):267-73. PubMed ID: 15459486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma.
    Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
    Urology; 2008 May; 71(5):928-32. PubMed ID: 18291512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
    Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.
    Silva SD; Agostini M; Nishimoto IN; Coletta RD; Alves FA; Lopes MA; Kowalski LP; Graner E
    Oral Oncol; 2004 Aug; 40(7):688-96. PubMed ID: 15172638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small renal tumors: correlation of clinical and pathological features with tumor size.
    Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
    J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.
    Merseburger AS; Serth J; von der Heyde E; Kobierski A; Wegener U; Mengel M; Jonas U; Kuczyk M
    Urol Int; 2007; 79(2):164-9. PubMed ID: 17851288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
    J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma.
    Seligson DB; Rajasekaran SA; Yu H; Liu X; Eeva M; Tze S; Ball W; Horvath S; deKernion JB; Rajasekaran AK
    J Urol; 2008 Jan; 179(1):338-45. PubMed ID: 18006011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
    Horiguchi A; Oya M; Shimada T; Uchida A; Marumo K; Murai M
    J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.